Irritable Bowel Syndrome and Digestive Health Support Forum banner
drug development
1-5 of 5 Results
  1. General Discussion
    As some of you may have seen by now the live bacterial formulation Blautix developed by 4D pharma produced some rather underwhelming results the other week in their Phase 2B (NCT03721107) IBS trial. I'll be going through the trial data more closely in this report and explain some details that...
  2. IBS Diarrhea (IBS-D)
    Orphomed is currently developing a new medication for IBS-D and is looking for patients who would like to participate in their Phase 2 Clinical Trial. ORP-101 as the medication is called, works by slowing down the intestinal transit while simultaneously easing abdominal pain. The ongoing Phase...
  3. General Discussion
    About 78% of IBS patients suffer from abdominal pain, a symptom which is often hard to treat and very debilitating for many sufferers as most of you will know. Now Arena Pharmaceuticals has started its Phase 2b clinical trial (NCT04043455) of its IBS-pain drug Olorinab and is looking for...
  4. General Discussion
    Recruitment for this study has ended, currently awating results. If you're an IBS-D patient and are looking for new treatment options this might be something for you. Boston Pharmaceuticals has just started a new trial to test its IBS drug BOS-589. The company has already successfully completed...
  5. General Discussion
    Last updated 2nd of October 2020 This is a comprehensive list of drugs currently in development to treat Irritable Bowel Syndrome. The format is made to be simple and self explanatory. In case this is not so I have provided some definitions below to guide unsure readers through each column...
1-5 of 5 Results
Top